Many patients diagnosed with type 1 diabetes who maintain C-peptide in this range can improve blood glucose levels with adjuvant (type 2 diabetes-associated) agents and/or discontinue insulin [28, 31]. The gene discussed is INS; the disease is type 2 diabetes mellitus.